CHAMPION-AF Clinical Trial - Boston Scientific
CHAMPION-AF Clinical Trial - Boston Scientific
Melanoma Survivor Becomes Advocate for Clinical Trials - Melanoma Research Alliance
CHAMPION-AF Clinical Trial - Boston Scientific
Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet
CLINICAL TRIALS - Spotlight on Quality in Study Startup: Automated Workflows Encourage Upfront Planning & Downstream Improvements in the eTMF
BostonSci Cardiology on Twitter: "With over 150,000 NVAF patients implanted with WATCHMAN #LAAC Solution devices, CHAMPION-AF evaluates the WATCHMAN FLX™ device as a safe and effective first-line option vs. NOAC for stroke
CHAMPION Trial Rationale and Design: The Long-Term Safety and Clinical Efficacy of a Wireless Pulmonary Artery Pressure Monitoring System - ScienceDirect
CHAMPION-AF Clinical Trial - Boston Scientific
BostonSci Cardiology on Twitter: "TRIAL ANNOUNCEMENT: We are excited to announce the intent to initiate CHAMPION-AF: a randomized head-to-head trial designed to study WATCHMAN FLX™ versus DOACs in patients with non-valvular AF
Lessons learned about the effective operationalization of champions as an implementation strategy: results from a qualitative process evaluation of a pragmatic trial | Center for Primary Care Research & Innovation
Tips on Cracking the CRO Procurement Process
Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet
CHAMPION-AF Patient Selection - Boston Scientific
Trial Design: CHAMPION-MG | ULTOMIRIS® (ravulizumab-cwvz) | gMG
Hemodynamic Monitoring for Heart Failure Patients
Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet
Trial Design: CHAMPION-MG | ULTOMIRIS® (ravulizumab-cwvz) | gMG
Embedding Clinical Trials into Clinical Practice - CTTI
BostonSci Cardiology on Twitter: "The CHAMPION-AF clinical trial aims to expand a first-line #LAAC option to lower risk patients by evaluating LAAC in patients with CHA₂DS₂-VASc scores of ≥ 2 for men
CardioMEMS HF System Clinical Evidence | Abbott
